Introducing Viraleze nasal spray to prevent Covid-19
On December 4, the People’s Court Magazine in collaboration with TAF Medical Equipment Joint Stock Company held a press conference to announce and introduce the Viraleze nasal spray product with antiviral effects against SARS-CoV-2 in the market. Vietnam.
Speaking at the press conference, Mr. Tran Quoc Viet, Editor-in-Chief of People’s Court Magazine, said that in the context of the Covid-19 epidemic, there are unpredictable developments, for effective prevention, in addition to compliance With 5K measures and vaccines, many famous pharmaceutical companies in the world have researched products to help health, prevent viruses, and provide an opportunity to protect people’s safety from new attacks of the virus. endanger life.
In particular, the antiviral Viraleze nasal spray is a compact, convenient product with proven effectiveness that will contribute to the prevention of Covid-19, bringing safety to users.
This is a product of Starpharma Technology Company based in Melbourne, Australia, announced by the Hanoi Department of Health and officially circulated in Vietnam from November 30, 2021, License Number 21000201 /PCBA-HN.
“The launch of a product to protect people’s health against the spread of the virus is an extremely practical and meaningful activity,” emphasized Mr. Viet.
Ms. Nguyen Thu Trang, representative of TAF MEDICAL Company – the distributor of Viraleze aerosol products in Vietnam, said that Viraleze antiviral spray is not a drug, classified as a group A medical device.
Data published by the manufacturer on June 18, 2021 shows that the active ingredients in Viraleze anti-viral nasal spray are 99.99% more effective against 3 out of 4 variants of the SARS-CoV virus. -2, and is also highly effective in prevention against new variants such as Delta and Omicron. Viraleze aerosol has many special advantages to create a health protection barrier, useful for everyone’s health in crowded activities.
Doctor Vu Quang Hung, Deputy Head of the Department of Chemical Therapy, National Institute of Hematology and Blood Transfusion, said that the variants of the SARS-CoV-2 virus are basically the same, only changing in some factors. , therefore, the protective mechanism of the nasal spray Viraleze with the active ingredient also provides a high preventive effect against the new variants.
Viraleze antiviral nasal spray is a product manufactured by Starpharma Biotechnology Company, based in Melbourne, Australia, imported and distributed by Nam Thanh Company and TAF Company in Vietnam.
The product has been issued by the Ministry of Health with file code 000.00.19 H26-211119,0007, published number 210002011/PCBA-HN dated 30/11/2021.